Advisor

How Is AI Impacting Pharma and Biotech?

Posted June 4, 2019 | Technology |
Pharma and Biotech

Identifying and developing new drugs and conducting clinical trials involve complex and lengthy (i.e., costly) processes that require researchers and drug manufacturers to integrate, manage, and analyze incredible amounts of data while at the same time collaborate with other medical research and pharma companies in their efforts. Pharmaceutical and biotechnology companies are using artificial intelligence (AI) to optimize the discovery and evaluation of new drug compounds, to explore patient and efficacy data, and to develop and bring new therapies to market.

About The Author
Curt Hall
Curt Hall is a Cutter Expert and a member of Arthur D. Little’s AMP open consulting network. He has extensive experience as an IT analyst covering technology and application development trends, markets, software, and services. Mr. Hall's expertise includes artificial intelligence (AI), machine learning (ML), intelligent process automation (IPA), natural language processing (NLP) and conversational computing, blockchain for business, and customer… Read More
Don’t have a login? Make one! It’s free and gives you access to all Cutter research.